Customer Care

We are here to support you every step of the way!

Most Common Questions

  • What is a Master Label?

    Show Answer

    The Master Label contains all of the approved uses for a given pesticide product and all associated labeling. Master Labels must be submitted for EPA approval. EPA-approved Master Labels are stamped “ACCEPTED” and placed in the official record. Labeling for a given product must not contain any text beyond that which is approved in the Master Label, except for supplemental labeling. The Master Label provides critical information about how to handle and use the pesticide product.

  • What important information can be found on the Master Label?

    Show Answer
    • Company name and address
    • EPA Registration number – indicates which company holds the registration for the pesticide product, and in what sequence the product was submitted to EPA by the company.
    • EPA Establishment number – The final physical location where the pesticide product was produced or labeled.
    • Efficacy Claims
    • Product Toxicity category
    • Directions for use
    • Storage and Disposal Directions
    • Product contact time
    • First Aid and Precautionary statements
    • Marketing claims
  • Can Sani-HyPerCide Spray be used with an Electrostatic Sprayer?

    Show Answer

    Yes, Sani-HyPerCide Spray can be used with an Electrostatic Sprayer on hard, nonporous surfaces only. The ability to use Sani-HyPerCide Spray with an Electrostatic Sprayer can be especially useful in Environmental Services.

  • Does Sani-HyPerCide Disinfectant have a Biofilm Bacteria kill claim?

    Show Answer

    Yes, Sani-HyPerCide Spray has a Biofilm Bacteria kill claim for S. aureus and P. aeruginosa at 3 minutes. Sani-HyPerCide Spray is useful for targeting these specific organisms in areas such as sinks and drains where biofilm is known to build up. Sani-HyPerCide Wipe does not have a Biofilm Bacteria kill claim.

  • Is the CAD technology/antimicrobial protective shield noticeable once applied?

    Show Answer

    When used as directed, the Sani-24 Wipe’s CAD/protective shield provides protection against ESKAPE pathogens for up to 24 hours – even after multiple touches. Once dried, the visibility of the protective shield varies depending on surfaces/materials, humidity, user technique, etc.

  • Would CAD technology be effective at 5-minute contact time for the microorganisms with contact times of 5 minutes such as Norovirus?

    Show Answer

    No, CAD technology is only listed as effective against ESKAPE pathogens per EPA master label.

  • How can ATP testing be used to validate continuously active disinfection (CAD) with the Sani-24 Wipe?

    Show Answer

    If the ATP testing should not be used to validate the Sani-24 Wipe. ATP testing is meant to validate cleaning processes. Further, the different ATP technologies can vary in sensitivity and can be impacted by disinfectant chemistry. Also, ATP testing detects both live and dead bacteria, and the CAD is intended to provide organism kill for up to 24 hours/96 touches. As a result, ATP reads may detect dead organisms and therefore produce false positive results with increased relative light unit (RLU) measurement.

  • How can the CAD shield be removed from the surface if any noticeable buildup occurs?

    Show Answer

    If the CAD shield needs to be removed, utilize a solvent/alcohol-based product (ex. Easy Screen Cleaning Wipe®, Super Sani-Cloth® Wipe). Once the surface is cleaned using a solvent or alcohol-based product, the Sani-24 Wipe must be reapplied to achieve CAD.

  • What if the CAD shield is wiped from the surface?

    Show Answer

    If the surface with CAD shield is wiped with a solvent/alcohol-based product, the Sani-24 Wipe must be reapplied to achieve CAD.

  • How harmful are the ESKAPE pathogens in respect to Healthcare Associated Infections (HAIs)?

    Show Answer

    The ESKAPE pathogens are responsible for over 40% of HAIs in the healthcare environment1,2.


    1. Magill, Multistate Point-Prevalence Survey of Health Care–Associated Infections, N Engl J Med 2014;370:1198-208
    2. Boucher, Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America, Clinical Infectious Diseases 2009; 48:1–12

Talk to a Specialist

Can’t find what you’re looking for? Complete the digital contact form.

Digital Contact Form

Need Help

Confused on how it all works? Here’s the step-by-step guide.